Surfactant protein B in chronic heart failure: An examination of the alveolocapillary barrier;Proteína surfactante tipo B en la insuficiencia cardiaca crónica: un examen de la barrera alveolocapilar

Revista Espanola de Cardiologia

Volumn 62, Issue 2, 2009, Pages 117-119

  De Pasquale, Carmine G ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN B;

EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG DIFFUSION; MITRAL VALVE STENOSIS;

BLOOD-AIR BARRIER; CAPILLARIES; CHRONIC DISEASE; HEART FAILURE; HUMANS; PULMONARY ALVEOLI; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B;

EID: 60649095230     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70152-6     Document Type: Editorial

References (16)

1. Guía de Práctica Clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Rev Esp Cardiol. 2008; 61:1329.e1-e70.
2. Pascual-Figal D.A., Sánchez-Más J., De la Morena G., Casas T., Garrido I.P., Ruipérez J.A., et al. Proteína surfactante pulmonary tipo B en circulación periférica y deterioro funcional en pacientes con insuficiencia cardiaca crónica. Rev Esp Cardiol 62 (2009) 136-142
3. West J.B., and Mathieu-Costello O. Vulnerability of pulmonar capillaries in heart disease. Circulation 92 (1995) 622-631
4. Pugin J., Verghese G., Widmer M.C., and Matthay M. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27 (1999) 304-312
5. Townsley M.I., Snell K.S., Ivey C.L., Culberson D.E., Liu D.C., Reed R.K., et al. Remodeling of lung interstitium but not resistance vessels in canine pacing-induced heart failure. J Appl Physiol 87 (1999) 1823-1830
6. Hermans C., and Bernard A. Lung epithelium-specific proteins. Characteristics and potential applications as markers. Am J Respir Crit Care Med 159 (1999) 646-678
7. Doyle I.R., Nicholas T.E., and Bersten A.D. Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability. Clin Exp Pharmacol Physiol 26 (1999) 185-197
8. Hermans C., and Bernard A. Pneumoproteinaemia: a new perspective in the assessment of lung disorders. Eur Respir J 11 (1998) 801-803
9. Doyle I.R., Nicholas T.E., and Bersten A.D. Surfactant proteins A and B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 156 (1997) 1217-1229
10. De Pasquale C.G., Arnolda L.F., Doyle I.R., Grant R.L., Aylward P.E., and Bersten A.D. Prolonged alveolocapillary barrier damage following acute cardiogenic pulmonary edema. Crit Care Med 31 (2003) 1060-1067
11. De Pasquale C.G., Arnolda L.F., Doyle I.R., Aylward P.E., Chew D.P., and Bersten A.D. Plasma surfactant protein-B: a novel biomarker in chronic heart failure. Circulation 110 (2004) 1091-1096
12. Townsley M.I., Fu Z., Mathieu-Costello O., and West J.B. Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacing-induced heart failure in dogs. Circ Res 77 (1995) 317-325
13. Lee Y.S. Electron microscopic studies of the alveolar-capillary barrier in the patients of chronic pulmonary edema. Jpn Circ J 43 (1979) 945-954
14. Wasserman K., Zhang Y.Y., Gitt A., Belardinelli R., Koike A., Lubarsky L., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 96 (1997) 2221-2227
15. De Pasquale C.G., Bersten A.D., Doyle I.R., Aylward P.E., and Arnolda L.F. Infarct-induced chronic heart failure increases bi-directional protein movement across the alveolocapillary barrier. Am J Physiol (Heart Circ Physiol) 284 (2003) H2136-H2145
16. Francis D.P., Shamin W., Ceri Davis L., Piepoli M.F., Ponikowski P., Anker S.D., et al. Cardiopulmonary exercise testing for prognosis in heart failure: continuous and independent prognostic values from VE/VCO2 slope and peak VO2. Eur Heart J 21 (2000) 154-161